Johnson & Johnson SG&A decreased by 10.6% to $6.03B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 18.0%, from $5.11B to $6.03B. Over 4 years (FY 2021 to FY 2025), SG&A shows an upward trend with a 4.2% CAGR. This increase may warrant attention — for this metric, lower values are generally preferred.
Analysis
How to read this metric
A rising ratio of SG&A to revenue may indicate inefficiency or aggressive expansion, while a falling ratio suggests improved operating leverage.
Detailed definition
Selling, general, and administrative expenses encompass the costs associated with the day-to-day operation of the busine...
Peer comparison
Standard operating expense category; peers with larger global sales forces typically show higher absolute SG&A levels.
selling_general_and_administrativeHistorical Data
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $6.07B | $6.00B | $2.61B | $5.94B | $6.23B | $4.98B | $5.34B | $4.91B | $5.40B | $5.40B | $5.81B | $5.26B | $5.68B | $5.48B | $6.45B | $5.11B | $5.89B | $5.92B | $6.75B | $6.03B |
| QoQ Change | — | -1.2% | -56.5% | +127.2% | +4.9% | -20.1% | +7.3% | -8.1% | +10.0% | +0.1% | +7.6% | -9.5% | +8.1% | -3.6% | +17.8% | -20.8% | +15.2% | +0.6% | +14.0% | -10.6% |
| YoY Change | — | — | — | — | +2.5% | -17.1% | +104.3% | -17.4% | -13.3% | +8.5% | +8.8% | +7.2% | +5.3% | +1.4% | +11.1% | -2.8% | +3.7% | +8.1% | +4.6% | +18.0% |
Product Breakdown
| Segment | FY'23 | FY'24 |
|---|---|---|
| Shipping and Handling | $900.00M | $900.00M |
| Total | $21.51B | $22.87B |
All segment values are derived from annual filings.
Business Segments
| Segment | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 |
|---|---|---|---|---|---|
| Innovative Medicine | $2.26B | $2.79B | $2.87B | $3.46B | $2.92B |
| MEDTECH | $2.66B | $2.86B | $2.80B | $3.04B | $2.91B |
| Total | $5.11B | $5.89B | $5.92B | $6.75B | $6.03B |
SG&A at Other Companies
Frequently Asked Questions
- What is Johnson & Johnson's sg&a?
- Johnson & Johnson (JNJ) reported sg&a of $6.03B in Q1 2026.
- How has Johnson & Johnson's sg&a changed year-over-year?
- Johnson & Johnson's sg&a increased by 18.0% year-over-year, from $5.11B to $6.03B.
- What is the long-term trend for Johnson & Johnson's sg&a?
- Over 4 years (2021 to 2025), Johnson & Johnson's sg&a has grown at a 4.2% compound annual growth rate (CAGR), from $20.12B to $23.68B.
- What does sg&a mean?
- The overhead costs of running the business, including sales, marketing, and general corporate expenses.